| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Clinical Cancer Research, Vol 2, Issue 5 855-863, Copyright © 1996 by American Association for Cancer Research
ARTICLES |
N Oridate, D Lotan, XC Xu, WK Hong and R Lotan
Departments of Tumor Biology and Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
Retinoids have been shown to act as cytostatic agents against a variety of tumor cell types, including squamous carcinoma cells. Recently it was reported that certain retinoids can induce apoptosis as well. Because we are investigating the potential of retinoids in chemoprevention and therapy for head and neck premalignant and malignant lesions, we compared the effects of all-trans-retinoic acid (ATRA) and N-(4-hydroxyphenyl)retinamide (4HPR) on seven human head and neck squamous cell carcinoma cell lines (17A, 17B, 22A, 22B, 38, SqCC/Y1, and 1483). Six of the seven cell lines showed dramatic morphological changes after treatment with 10 micrometer 4HPR, whereas no such changes were induced by 10 micrometer ATRA. To determine whether these retinoids can induce apoptosis, we analyzed both detached and attached cells after 2, 5, and 7 days of treatment for evidence of DNA fragmentation by DNA electrophoresis on agarose gels. In five of the seven cell lines, a DNA ladder was observed after treatment with 10 micrometer 4HPR for 5 or 7 days, whereas treatment with ATRA resulted in a less pronounced effect. In 17B cells, a clear DNA ladder was observed as early as 2 days after treatment with 4HPR; however, neither ATRA nor 9-cis-retinoic acid was as effective. In addition, morphological changes associated with apoptotic cell death, such as chromatin condensation and nuclear segmentation, were observed by propidium iodide staining and by electron microscopic analysis after 4HPR treatment. These results demonstrate that 4HPR causes apoptosis in several head and neck squamous cell carcinoma cell lines and that it is more potent in this effect than ATRA.
This article has been cited by other articles:
|
|
 |
|
  A. L. Sabichi, S. P. Lerner, E. N. Atkinson, H. B. Grossman, N. P. Caraway, C. P. Dinney, D. F. Penson, S. Matin, A. Kamat, L. L. Pisters, et al. Phase III Prevention Trial of Fenretinide in Patients with Resected Non Muscle-Invasive Bladder Cancer Clin. Cancer Res., January 1, 2008; 14(1): 224 - 229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Lippman, J. J. Lee, J. W. Martin, A. K. El-Naggar, X. Xu, D. M. Shin, M. Thomas, L. Mao, H. A. Fritsche Jr., X. Zhou, et al. Fenretinide Activity in Retinoid-Resistant Oral Leukoplakia. Clin. Cancer Res., May 15, 2006; 12(10): 3109 - 3114. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Xu, S. Cheepala, E. McCauley, K. Coombes, L. Xiao, S. M. Fischer, and J. L. Clifford Chemoprevention of Skin Carcinogenesis by Phenylretinamides: Retinoid Receptor-Independent Tumor Suppression Clin. Cancer Res., February 1, 2006; 12(3): 969 - 979. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Rigas and K. H. Dragnev Emerging Role of Rexinoids in Non-Small Cell Lung Cancer: Focus on Bexarotene Oncologist, January 1, 2005; 10(1): 22 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.S. Prime, M. Davies, M. Pring, and I.C. Paterson THE ROLE OF TGF-{beta} IN EPITHELIAL MALIGNANCY AND ITS RELEVANCE TO THE PATHOGENESIS OF ORAL CANCER (PART II) Crit. Rev. Oral. Biol. Med., November 1, 2004; 15(6): 337 - 347. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-Y. Sun, N. Hail Jr, and R. Lotan Apoptosis as a Novel Target for Cancer Chemoprevention J Natl Cancer Inst, May 5, 2004; 96(9): 662 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-J. Kim and R. Lotan Identification of Retinoid-Modulated Proteins in Squamous Carcinoma Cells Using High-Throughput Immunoblotting Cancer Res., April 1, 2004; 64(7): 2439 - 2448. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Sabichi, H. Xu, S. Fischer, C. Zou, X. Yang, V. E. Steele, G. J. Kelloff, R. Lotan, and J. L. Clifford Retinoid Receptor-Dependent and Independent Biological Activities of Novel Fenretinide Analogues and Metabolites Clin. Cancer Res., October 1, 2003; 9(12): 4606 - 4613. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Matsushima-Nishiwaki, M. Okuno, Y. Takano, S. Kojima, S. L. Friedman, and H. Moriwaki Molecular mechanism for growth suppression of human hepatocellular carcinoma cells by acyclic retinoid Carcinogenesis, August 1, 2003; 24(8): 1353 - 1359. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Sabichi, M. R. Modiano, J. J. Lee, Y.-M. Peng, M.-J. Xu, H. Villar, W. S. Dalton, and S. M. Lippman Breast Tissue Accumulation of Retinamides in a Randomized Short-term Study of Fenretinide Clin. Cancer Res., July 1, 2003; 9(7): 2400 - 2405. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Zou, A.-T. Vlastos, L. Yang, J. Wang, M. Brewer, and M. Follen Effect of 4-Hydroxyphenylretinamide on Human Cervical Epithelial and Cancer Cell Lines Reproductive Sciences, January 1, 2003; 10(1): 41 - 48. [Abstract] [PDF]
|
|
|
|
 |
|
 D.-G. Kim, K.-R. You, M.-J. Liu, Y.-K. Choi, and Y.-S. Won GADD153-mediated Anticancer Effects of N-(4-Hydroxyphenyl)retinamide on Human Hepatoma Cells J. Biol. Chem., October 4, 2002; 277(41): 38930 - 38938. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bruno, C. Tenca, D. Saverino, E. Ciccone, and C. E. Grossi Apoptosis of squamous cells at different stages of carcinogenesis following 4-HPR treatment Carcinogenesis, March 1, 2002; 23(3): 447 - 456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Shin, F. R. Khuri, B. Murphy, A. S. Garden, G. Clayman, M. Francisco, D. Liu, B. S. Glisson, L. Ginsberg, V. Papadimitrakopoulou, et al. Combined Interferon-Alfa, 13-cis-Retinoic Acid, and Alpha-Tocopherol in Locally Advanced Head and Neck Squamous Cell Carcinoma: Novel Bioadjuvant Phase II Trial J. Clin. Oncol., June 15, 2001; 19(12): 3010 - 3017. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-Y. Sun, P. Yue, G. J. Kelloff, V. E. Steele, S. M. Lippman, W. K. Hong, and R. Lotan Identification of Retinamides That Are More Potent than N-(4-Hydroxyphenyl)retinamide in Inhibiting Growth and Inducing Apoptosis of Human Head and Neck and Lung Cancer Cells Cancer Epidemiol. Biomarkers Prev., June 1, 2001; 10(6): 595 - 601. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. R. Khuri, J. R. Rigas, R. A. Figlin, R. J. Gralla, D. M. Shin, R. Munden, N. Fox, M. R. Huyghe, Y. Kean, S. D. Reich, et al. Multi-Institutional Phase I/II Trial of Oral Bexarotene in Combination With Cisplatin and Vinorelbine in Previously Untreated Patients With Advanced Non-Small-Cell Lung Cancer J. Clin. Oncol., May 15, 2001; 19(10): 2626 - 2637. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Guruswamy, S. Lightfoot, M. A. Gold, R. Hassan, K. D. Berlin, R. T. Ivey, and D. M. Benbrook Effects of Retinoids on Cancerous Phenotype and Apoptosis in Organotypic Cultures of Ovarian Carcinoma J Natl Cancer Inst, April 4, 2001; 93(7): 516 - 525. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Clifford, A. L. Sabichi, C. Zou, X. Yang, V. E. Steele, G. J. Kelloff, R. Lotan, and S. M. Lippman Effects of Novel Phenylretinamides on Cell Growth and Apoptosis in Bladder Cancer Cancer Epidemiol. Biomarkers Prev., April 1, 2001; 10(4): 391 - 395. [Abstract] [Full Text]
|
|
|
|
|
|
N. Hail Jr. and R. Lotan Mitochondrial Permeability Transition Is a Central Coordinating Event in N-(4-Hydroxyphenyl)retinamide-induced Apoptosis Cancer Epidemiol. Biomarkers Prev., December 1, 2000; 9(12): 1293 - 1301. [Abstract] [Full Text]
|
|
|
|
|
|
F. R. Khuri, R. Lotan, B. L. Kemp, S. M. Lippman, H. Wu, L. Feng, J. J. Lee, C. S. Cooksley, B. Parr, E. Chang, et al. Retinoic Acid Receptor-Beta as a Prognostic Indicator in Stage I Non-Small-Cell Lung Cancer J. Clin. Oncol., August 15, 2000; 18(15): 2798 - 2804. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Steiner, X. Zhang, Y. Wang, and Y. Lu Growth Inhibition of Prostate Cancer by an Adenovirus Expressing a Novel Tumor Suppressor Gene, pHyde Cancer Res., August 1, 2000; 60(16): 4419 - 4425. [Abstract] [Full Text]
|
|
|
|
|
|
J. M. Kurie, J. S. Lee, F. R. Khuri, L. Mao, R. C. Morice, J. J. Lee, G. L. Walsh, A. Broxson, S. M. Lippman, J. Y. Ro, et al. N-(4-Hydroxyphenyl)Retinamide in the Chemoprevention of Squamous Metaplasia and Dysplasia of the Bronchial Epithelium Clin. Cancer Res., August 1, 2000; 6(8): 2973 - 2979. [Abstract] [Full Text]
|
|
|
|
|
|
S.-Y. Sun, P. Yue, L. Mao, M. I. Dawson, B. Shroot, W. W. Lamph, R. A. Heyman, R. A. S. Chandraratna, K. Shudo, W. K. Hong, et al. Identification of Receptor-selective Retinoids That Are Potent Inhibitors of the Growth of Human Head and Neck Squamous Cell Carcinoma Cells Clin. Cancer Res., April 1, 2000; 6(4): 1563 - 1573. [Abstract] [Full Text]
|
|
|
|
 |
|
 V. A. Papadimitrakopoulou, G. L. Clayman, D. M. Shin, J. N. Myers, A. M. Gillenwater, H. Goepfert, A. K. El-Naggar, J. S. Lewin, S. M. Lippman, and W. K. Hong Biochemoprevention for Dysplastic Lesions of the Upper Aerodigestive Tract Arch Otolaryngol Head Neck Surg, October 1, 1999; 125(10): 1083 - 1089. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Picard, C. Seguin, N. Monhoven, C. Rochette-Egly, J. Siat, J. Borrelly, Y. Martinet, N. Martinet, and J. M. Vignaud Expression of Retinoid Receptor Genes and Proteins in Non-Small-Cell Lung Cancer J Natl Cancer Inst, June 16, 1999; 91(12): 1059 - 1066. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-Y. Sun, P. Yue, G. S. Wu, W. S. El-Deiry, B. Shroot, W. K. Hong, and R. Lotan Implication of p53 in Growth Arrest and Apoptosis Induced by the Synthetic Retinoid CD437 in Human Lung Cancer Cells Cancer Res., June 1, 1999; 59(12): 2829 - 2833. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-C. Xu, X. Liu, E. Tahara, S. M. Lippman, and R. Lotan Expression and Up-Regulation of Retinoic Acid Receptor-{beta} Is Associated with Retinoid Sensitivity and Colony Formation in Esophageal Cancer Cell Lines Cancer Res., May 1, 1999; 59(10): 2477 - 2483. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-Y. Sun, W. Li, P. Yue, S. M. Lippman, W. K. Hong, and R. Lotan Mediation of N-(4-Hydoxyphenyl)retinamide-induced Apoptosis in Human Cancer Cells by Different Mechanisms Cancer Res., May 1, 1999; 59(10): 2493 - 2498. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-Y. Sun, P. Yue, and R. Lotan Induction of Apoptosis by N-(4-Hydroxyphenyl)retinamide and Its Association with Reactive Oxygen Species, Nuclear Retinoic Acid Receptors, and Apoptosis-Related Genes in Human Prostate Carcinoma Cells Mol. Pharmacol., March 1, 1999; 55(3): 403 - 410. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. R. MESTRE, G. CHAN, F. ZHANG, E. K. YANG, P. G. SACKS, J. O. BOYLE, J. P. SHAH, D. EDELSTEIN, K. SUBBARAMAIAH, and A. J. DANNENBERG Inhibition of Cyclooxygenase-2 Expression: An Approach to Preventing Head and Neck Cancer Ann. N.Y. Acad. Sci., January 1, 1999; 889(1): 62 - 71. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Clifford, D. G. Menter, M. Wang, R. Lotan, and S. M. Lippman Retinoid Receptor-dependent and -independent Effects of N-(4-Hydroxyphenyl)retinamide in F9 Embryonal Carcinoma Cells Cancer Res., January 1, 1999; 59(1): 14 - 18. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
